Particular receptor tyrosine kinases (RTKs) that promote excessive cell division are found at high levels on various cancer cells. A protein, Herceptin, has been found to bind to an RTK known as HER2. HER2 is sometimes excessive in cancer cells. This information can now be utilized in breast cancer treatment if which of the following is true?

HER2 is Cancer cells of breast caner

Explanation:

HER2 is a development advancing protein outwardly of all bosom cells.These malignancies will in general develop and spread quicker than other bosom diseases, yet are significantly more liable to react to treatment with drugs that focus on the HER2 protein. It isn't clear in the event that one test is more precise than the other, however, FISH is increasingly costly and takes more time to get the outcomes.In the event that the IHC result is 3+, the malignant growth is HER2-positive. This implies the HER2 status should be tried with FISH to explain the outcome. Triple-negative bosom tumors have relatively little HER2 and furthermore don't have estrogen or progesterone receptors. Hormone treatment and medications that target HER2 are not useful in treating these malignant growths.Hence, the answer of information of cancer treatment is "true"